Author:
Kang H J,Chang H M,Kim T W,Ryu M-H,Sohn H J,Yook J H,Oh S T,Kim B S,Lee J-S,Kang Y-K
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Aabo K, Pedersen H, Rorth M (1985) Cisplatin in the treatment of advanced gastric carcinoma: a phase II study. Cancer Treat Rep 69: 449–450
2. Bae JM, Won WJ, Jung KW, Park JG (2002) Annual report of the Korea Central Cancer Registry Program 2000: based on registered data from 131 hospitals. Cancer Res Treat 34: 77–83
3. Cao S, Lu K, Ishitsuka H, Rustum YM (1997) Antitumor efficacy of capecitabine against fluorouracil-sensitive and -resistant tumours. Proc Am Soc Clin Oncol 16: 226a (abstr 795)
4. Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35: 1059–1064
5. Evans TR, Pentheroudakis G, Paul J, McInnes A, Blackie R, Raby N, Morrison R, Fullarton GM, Soukop M, McDonald AC (2002) A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. Ann Oncol 13: 1469–1478